A Look at Adderall Side Effects and Warnings
http://www.goarticles.com/cgi-bin/showa.cgi?C=288168
According to the Center for Disease Control (CDC) approximately 3,100 patients (both children and adults) end us in emergency rooms from accidental overdoses and side effects of ADHD drugs.
Almost two-thirds could be prevented by parents locking up the pills. Other side effects that drive patients to the ER include potential cardiac problems such as chest pain, stroke, high blood pressure, and fast heart rate.
Concerns over these side effects have led some doctors to urge the Food and Drug Administration to require a “black box” warning (the most serious warning) on package inserts for ADHD drugs such Adderall, Concerta, and Ritalin.
The issue was discussed in a series of letters in the New England Journal of Medicine, including some from doctors worried about the dangers of not treating attention deficit hyperactivity disorder. The doctors could not agree on whether or not the more serious warning was necessary.
About the Author
Monheit Law handles dangerous pharmaceutical cases, including Adderall stroke and heart attack cases.

ADHD (Attention-Deficit/Hyperactivity Disorder) is the term used in the more recently. ADD (Attention Deficit Disorder) with or without hyperactivity is the older term. Essentially, they’re the same disorder.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurological brain disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed at a comparable level of development.

On August 21, 2006 the FDA announced changes to ADHD drugs. These drugs warn of possible heart problems. Other problems include sudden deaths, strokes, and heart attacks reported in adults taking ADHD drugs like Adderall. The new labels also warn that pre-existing psychotic disorders, such as bipolar illness, may get worse. The advisory also noted new psychiatric symptoms, such as hallucinations or delusional thinking, may emerge with ADHD drugs. (USA Today)

It was hush-hush as the FDA barely announced its decision to require the makers of attention deficit drugs (like Adderall) to add labels on their drugs announcing heart problems and psychiatric warnings. This lack of enthusiasm was questioned by politicians as to the FDA’s loyalty toward pharmaceutical giants or the public safety.
Months after two FDA advisory panels offered conflicting opinions over the warnings, in May 2006 the FDA asked most ADHD drug makers to add warnings. Its decision was made public when the FDA released a letter GlaxoSmithKline, maker of Dexedrine, sent to doctors. Others include Adderall, Focalin, and Concerta.
Some analysts and doctors say the warnings are unlikely to affect the millions of ADHD prescriptions written each month. (Chron.com)

For children who suffer from Attention Deficit Hyperactivity Disorder (ADHD) and cannot sit calmly at one place, pipe down or follow instructions, there is a controversy over whether Adderall is an answer. Though mental health professionals and parents are familiar with the symptoms, the treatment of this disorder is still a controversial topic. http://www.medindia.net/news/view_news_main.asp?x=13963